✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

BioCryst Pharmaceuticals, Inc.

Common Name
BioCryst Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
435
Ticker
BCRX
Exchange
Nasdaq
Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing medicines for rare diseases, with a primary emphasis on hereditary angioedema (HAE). Its commercial ...

BioCryst Pharmaceuticals's Revenues Data

Explore BioCryst Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
874,837,000a
450,712,000a
331,412,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind BioCryst Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. BioCryst Pharmaceuticals's 10-K 2025